Medicare ACO Information

 
ACO name and location

Health Connect Partners, LLC
1801 SW Lind Avenue
Morin Building, 1st Floor
Renton, WA 98057

ACO primary contact

Dominique Buhl
253-881-5949
Send an email

Organizational Information

ACO participants

ACO Participants

ACO Participant in Joint Venture
Pet/Ct Imaging At Swedish Cancer Institute LLC
Y
Swedish Edmonds
N
Providence Health & Services- Washington

N

PROVIDENCE HEALTH & SERVICES WASHINGTON
N
Providence Health Serviceswa
N
Providence Medical Foundation
N
PROVIDENCE HEALTH & SERVICES – WASHINGTON
N
Providence Health Services Wa
N
PROVIDENCE HEALTH & SERVICES – WA
N
PACMED CLINICS
N
Providence St. Joseph Medical Center
N
Swedish Health Services
N
Providence Facey Medical Foundation
N
PROVIDENCE HEALTH & SERVICES OREGON
Y

ACO governing body

Member Last Name
Member First Name
Member Title/Position
Member's Voting Power
Membership Type
ACO Participant TIN Legal Business Name/DBA, if Applicable
Sadagopan
Deepak
ACO Chief Executive Officer
1
Other: ACO Chief Executive Officer
Providence Health & Services - Washington
Anders
Scott
ACO Chief Medical Officer
1
Other: Chief Medical Officer
Providence Health & Services – Washington
Meadows
Richard
CMO Ambulatory - Kadlec
0
Other: Medical Officer
Kadlec Regional Medical Center
Martin
James
Medical Director and Associate CMO
1
ACO Participant Representative
Swedish Health Services
Brown
Tamara
Chief Financial Officer
1
ACO Participant Representative
Providence Health & Services – Alaska
Rafeh
Zach
Chief Medical Officer SW PMG, PPN Administration
1
ACO Participant Representative
Providence Health & Services – Washington
Davidson
Timothy
Chief Executive Physician
1
ACO Participant Representative
Providence Health & Services – Washington
Ferguson
Monica
Physician
1
ACO Participant Representative
St. Joseph Heritage Health
Rogers
Terry
Medicare Beneficiary Representative, CEO for the Foundation for Health Care Quality
1
Medicare Beneficiary Representative
Medicare Beneficiary Representative
Campbell
Stephen
Chief Medical Officer, Northwest Region
1
ACO Participant Representative
Providence Health & Services – Washington
Mallo
Rebecca
Chief Medical Officer
1
ACO Participant Representative
Providence Health & Services – Washington
LeBlanc
Benjamin
Chief Executive, OR PMG
1
ACO Participant Representative
PROVIDENCE HEALTH & SERVICES OREGON
Shelton
Laura
Physician Leader-Montana region
1
ACO Participant Representative
Providence Health & Services – Montana
Wakai
Mark
Chief Population Health Officer WA/MT region
0
Other: Medical Officer
Providence Health & Services – WA/Montana

Key ACO clinical and administrative leadership

ACO Executive: Deepak Sadagopan
Medical Director: Scott Anders
Compliance Officer: Amy Riedel
Quality Assurance/Improvement Officer: Angie Beck

Associated committees and committee leadership

Committee Name
Committee Leader Name and Position
Operations, Analytics & Compliance Committee
Deepak Sadagopan – Chair
Governing Body Compliance Committee
Deepak Sadagopan – Chair

Types of ACO participants, or combinations of participants, that formed the ACO

  • ACO professionals in a group practice arrangement
  • Hospital employing ACO professionals
  • Partnerships or joint venture arrangements between hospitals and ACO professionals

Shared Savings and Losses

Amount of shared savings/losses

  • Third Agreement Period
    • Performance Year 2021, $19,867,717
    • Performance Year 2020, $26,113,601
  • Second Agreement Period
    • Performance Year 2019, $14,116,371
    • Performance Year 2018, $0
    • Performance Year 2017, $10,747,306
  • First Agreement Period
    • Performance Year 2016, $0
    • Performance Year 2015, $0
    • Performance Year 2014, $0

Shared savings distribution

Third Agreement Period

  • Performance Year 2021
    • Proportion invested in infrastructure: 0%
    • Proportion invested in redesigned care processes/resources: 0%
    • Proportion of distribution to ACO participants: 100%
  • Performance Year 2020
    • Proportion invested in infrastructure: 0%
    • Proportion invested in redesigned care processes/resources: 0%
    • Proportion of distribution to ACO participants: 100%

Second Agreement Period

  • Performance Year 2020
    • Proportion invested in infrastructure: 0%
    • Proportion invested in redesigned care processes/resources: 0%
    • Proportion of distribution to ACO participants: 100%
  • Performance Year 2019
    • Proportion invested in infrastructure: 0% 
    • Proportion invested in redesigned care processes/resources: 0% 
    • Proportion of distribution to ACO participants: 100% 
  • Performance Year 2018
    • Proportion invested in infrastructure: N/A
    • Proportion invested in redesigned care processes/resources: N/A
    • Proportion of distribution to ACO participants: N/A
  • Performance Year 2017
    • Proportion invested in infrastructure: 0%
    • Proportion invested in redesigned care processes/resources: 0%
    • Proportion of distribution to ACO participants: 100%

First Agreement Period

  • Performance Year 2016
    • Proportion invested in infrastructure: N/A
    • Proportion invested in redesigned care processes/resources: N/A
    • Proportion of distribution to ACO participants: N/A
  • Performance Year 2015
    • Proportion invested in infrastructure: N/A
    • Proportion invested in redesigned care processes/resources: N/A
    • Proportion of distribution to ACO participants: N/A
  • Performance Year 2014
    • Proportion invested in infrastructure: N/A
    • Proportion invested in redesigned care processes/resources: N/A
    • Proportion of distribution to ACO participants: N/A

Quality Performance Results

2021 quality performance results

Quality performance results are based on CMS Web Interface.

Measure #

Measure Name

Rate

ACO Mean

001
Diabetes: Hemoglobin A1c (HbA1c) Poor Control2
12.65
12.46
134
Preventative Care and Screening: Screening for Depression and Follow-up Plan
81.79
74.38
236
Controlling High Blood Pressure
72.05
74.87
318
Falls: Screening for Future Fall Risk
81.82
87.03
110
Preventative Care and Screening: Influenza Immunization
74.8
80.52
226
Preventative Care and Screening: Tobacco Use: Screening and Cessation Intervention
64.29
80.97
113
Colorectal Cancer Screening
75.17
73.63
112
Breast Cancer Screening
78.12
75.11
438
Statin Therapy for the Prevention and Treatment of Cardiovascular Disease
82.46
84.24
479
Hospital-Wide, 30-Day, All-Cause Unplanned Readmission (HWR) Rate for MIPS Groups
0.1350
0.1540
MCC1
All-Cause Unplanned Admissions for Patients with Multiple Chronic Conditions for ACOs (MCC)
27.53
33.99
CAHPS-1
Getting Timely Care, Appointments, and Information
74.81
84.67
CAHPS-2
How Well Providers Communicate
90.88
93.56
CAHPS-3
Patient’s Rating of Provider
88.11
92.19
CAHPS-4
Access to Specialists
71.79
78.80
CAHPS-5
Health Promotion and Education
60.07
61.61
CAHPS-6
Shared Decision Making
53.85
60.89
CAHPS-7
Health Status and Functional Status
68.26
71.78
CAHPS-8
Care Coordination
81.98
85.66
CAHPS-9
Courteous and Helpful Office Staff
89.41
91.88
CAHPS-11
Stewardship of Patient Resources
19.91
24.71

Please note, the Quality ID #: 370 Depression Remission at 12 months quality measure is not included in public reporting  due to low sample size.

For previous years’ financial and quality performance results, please visit data.cms.gov.

Payment Rule Waivers

Skilled Nursing Facility (SNF) 3-day Rule Waiver
Our ACO uses the SNF 3-Day Rule Waiver, pursuant to 42 CFR § 425.612.